Sym024
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sym024, covering 2024-12-09 to 2024-12-09. Get the full timeline:
Most recent: Clinical Trial Update: Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies [Phase 1]